Questioning Conclusions and Statements on the German HTA System: A Critical Perspective.

Tomeczkowski, Jörg; Heidbrede, Tanja; Leverkus, Friedhelm; Schmitter, Sarah; Dintsios, Charalabos-Markos; Osowski, Ulrike; Herrmann, Kirsten H; Bluhmki, Tobias; Marx, Almuth; Eichinger, Birte; Basic, Edin; Bussilliat, Paul; Dietrich, Eva Susanne

Tomeczkowski, Jörg; Heidbrede, Tanja; Leverkus, Friedhelm; Schmitter, Sarah; Dintsios, Charalabos-Markos; Osowski, Ulrike; Herrmann, Kirsten H; Bluhmki, Tobias; Marx, Almuth; Eichinger, Birte; Basic, Edin; Bussilliat, Paul; Dietrich, Eva Susanne.

Afiliación

Tomeczkowski J; Institute for Evidence-Based Positioning in the Health Care Sector at the University of Bonn, Bonn, Germany.
Heidbrede T; UCB BioSciences, Monheim, Germany.
Leverkus F; Pfizer Pharma, Berlin, Germany.
Schmitter S; Pfizer Pharma, Berlin, Germany.
Dintsios CM; Institute for Health Services Research and Health Economics, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Osowski U; Merck Healthcare Germany, Darmstadt, Germany.
Herrmann KH; Pharming, Ottobrunn, Germany.
Bluhmki T; Bristol-Myers Squibb, Munich, Germany.
Marx A; Novartis AG, Nuremberg, Germany.
Eichinger B; Novartis AG, Nuremberg, Germany.
Basic E; Berlin School of Economics and Law, Berlin, Germany.
Bussilliat P; vfa Berlin, Berlin, Germany.
Dietrich ES; Institute for Evidence-Based Positioning in the Health Care Sector at the University of Bonn, Bonn, Germany.

Clin Pharmacol Ther ; 2024 May 09.

Article en En | MEDLINE | ID: mdl-38721790

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Pharmacol Ther Año: 2024 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google